Arrow Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-10
| Closed | -$2K | – | 324 |
|
2019
Q2 | $2K | Sell |
10
-990
| -99% | -$198K | ﹤0.01% | 333 |
|
2019
Q1 | $236K | Buy |
+1,000
| New | +$236K | 0.05% | 161 |
|
2018
Q4 | – | Sell |
-1,065
| Closed | -$376K | – | 365 |
|
2018
Q3 | $376K | Buy |
1,065
+1,000
| +1,538% | +$353K | 0.08% | 146 |
|
2018
Q2 | $19K | Hold |
65
| – | – | ﹤0.01% | 262 |
|
2018
Q1 | $18K | Sell |
65
-5,000
| -99% | -$1.38M | ﹤0.01% | 268 |
|
2017
Q4 | $1.61M | Hold |
5,065
| – | – | 0.37% | 73 |
|
2017
Q3 | $1.59M | Hold |
5,065
| – | – | 0.38% | 71 |
|
2017
Q2 | $1.38M | Hold |
5,065
| – | – | 0.33% | 78 |
|
2017
Q1 | $1.39M | Sell |
5,065
-1,025
| -17% | -$280K | 0.34% | 79 |
|
2016
Q4 | $1.73M | Sell |
6,090
-120
| -2% | -$34K | 0.43% | 75 |
|
2016
Q3 | $1.94M | Sell |
6,210
-725
| -10% | -$227K | 0.49% | 65 |
|
2016
Q2 | $1.68M | Sell |
6,935
-4,202
| -38% | -$1.02M | 0.44% | 74 |
|
2016
Q1 | $2.9M | Sell |
11,137
-2,229
| -17% | -$580K | 0.77% | 41 |
|
2015
Q4 | $4.1M | Buy |
13,366
+2,649
| +25% | +$812K | 1.09% | 26 |
|
2015
Q3 | $3.13M | Buy |
10,717
+1,572
| +17% | +$459K | 0.89% | 34 |
|
2015
Q2 | $3.69M | Buy |
9,145
+836
| +10% | +$338K | 1% | 33 |
|
2015
Q1 | $3.51M | Sell |
8,309
-456
| -5% | -$193K | 0.94% | 34 |
|
2014
Q4 | $2.98M | Buy |
8,765
+3,425
| +64% | +$1.16M | 0.81% | 40 |
|
2014
Q3 | $1.77M | Buy |
5,340
+1,000
| +23% | +$331K | 0.49% | 70 |
|
2014
Q2 | $1.37M | Sell |
4,340
-2,780
| -39% | -$876K | 0.37% | 89 |
|
2014
Q1 | $2.18M | Sell |
7,120
-880
| -11% | -$269K | 0.62% | 56 |
|
2013
Q4 | $2.24M | Buy |
8,000
+500
| +7% | +$140K | 0.64% | 56 |
|
2013
Q3 | $1.81M | Hold |
7,500
| – | – | 0.55% | 64 |
|
2013
Q2 | $1.61M | Buy |
+7,500
| New | +$1.61M | 0.52% | 68 |
|